1393883-03-8Relevant articles and documents
Quinolinyl pyrimidines: Potent inhibitors of NDH-2 as a novel class of anti-TB agents
Shirude, Pravin S.,Paul, Beena,Roy Choudhury, Nilanjana,Kedari, Chaitanya,Bandodkar, Balachandra,Ugarkar, Bheemarao G.
supporting information, p. 736 - 740 (2012/10/29)
NDH-2 is an essential respiratory enzyme in Mycobacterium tuberculosis (Mtb), which plays an important role in the physiology of Mtb. Herein, we present a target-based effort to identify a new structural class of inhibitors for NDH-2. High-throughput screening of the AstraZeneca corporate collection resulted in the identification of quinolinyl pyrimidines as the most promising class of NDH-2 inhibitors. Structure-activity relationship studies showed improved enzyme inhibition (IC50) against the NDH-2 target, which in turn translated into cellular activity against Mtb. Thus, the compounds in this class show a good correlation between enzyme inhibition and cellular potency. Furthermore, early ADME profiling of the best compounds showed promising results and highlighted the quinolinyl pyrimidine class as a potential lead for further development.